New therapeutic strategy for chemotherapy resistance in ovarian cancer

A Wistar study demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of stem-like chemoresistant cells following cisplatin treatment.

Read the full article here

Related Articles